Compare KLA Corp. (KLAC) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KLA Corp. vs Teladoc Health Inc — how do they compare? KLA Corp. trades at $216.73 (market cap $271.18B), while Teladoc Health Inc trades at $9.7 (market cap $1.74B). The key difference: KLA Corp. is far larger — about 155.9× Teladoc Health Inc's market cap, and KLA Corp. pays a 0.44% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| KLAC | TDOC | |
|---|---|---|
Market Cap | $271.18B | $1.74B |
Sector | Technology | Health |
52-Week High | $301.71 | $9.72 |
52-Week Low | $84.39 | $4.47 |
Enterprise Value | $272.37B | $2.03B |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KLA Corporation (KLAC) trades at $217.56, up 2.26% today, showing strong momentum after recent earnings beats. The stock maintains bullish technical signals with RSI levels indicating potential oversold conditions. Fundamentally, KLAC demonstrates robust profitability with 35.66% net income margin and consistent revenue growth, though valuation ratios remain elevated. Recent corporate actions include a 1:10 stock split and $2.30 dividend payment, reflecting management confidence.
KLAC presents a compelling growth story with dominant semiconductor process control positioning, but faces valuation concerns and sector volatility risks. Analyst consensus remains bullish with $242.49 price target, though near-term headwinds from semiconductor market correction require careful monitoring. The company's strong cash flow generation and AI-driven equipment demand support long-term upside potential.
TDOC trades at $9.71, up 2.97% with a bullish technical signal. The stock shows improving fundamentals with revenue stabilizing around $2.5B and narrowing losses. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026. Positive sentiment is driven by partnerships like Walmart Better Care and cost-cutting initiatives, though net margins remain negative.
The outlook suggests cautious optimism as operational improvements may drive recovery, but persistent losses and high debt pose risks. Analyst consensus is mixed with 36% buy ratings and a $9.50 price target, indicating limited upside. Investors should weigh cost-control progress against competitive pressures in telehealth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
